Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Walton

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Cancer Research|January 18, 2011
CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitorsVictoria E Anderson, Michael I Walton, Paul D Eve, et al.
Chemical Communications (Cambridge, England)|September 13, 2012
Tuning the breathing behaviour of MIL-53 by cation mixingFarid Nouar, Thomas Devic, Hubert Chevreau, et al.
Dalton Transactions (Cambridge, England : 2003)|December 6, 2021
Investigation of the preparation and reactivity of metal-organic frameworks of cerium and pyridine-2,4,6-tricarboxylateJuliana Fonseca de Lima, Fernanda V S Moreno, Bruno A T Menezes, et al.
Molecular Cancer Therapeutics|January 8, 2010
The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106Michael I Walton, Paul D Eve, Angela Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202Florence I Raynaud, Steven R Whittaker, Peter M Fischer, et al.
Journal of Medicinal Chemistry|July 4, 2009
Identification of inhibitors of checkpoint kinase 1 through template screeningThomas P Matthews, Suki Klair, Samantha Burns, et al.
Inorganic Chemistry|December 23, 2017
23-Electron Octahedral Molybdenum Cluster Complex [{Mo<sub>6</sub>I<sub>8</sub>}Cl<sub>6</sub>]<sup></sup>Natalya A Vorotnikova, Yuri A Vorotnikov, Igor N Novozhilov, et al.
Genome Biology|September 17, 2016
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancerNnennaya Kanu, Maria Antonietta Cerone, Gerald Goh, et al.
Molecular Cancer Therapeutics|April 29, 2010
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growthKyla M Grimshaw, Lisa-Jane K Hunter, Timothy A Yap, et al.
Journal of Medicinal Chemistry|October 23, 2012
Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitorsMichael Lainchbury, Thomas P Matthews, Tatiana McHardy, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Cancer Research|January 18, 2011
CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitorsVictoria E Anderson, Michael I Walton, Paul D Eve, et al.
Chemical Communications (Cambridge, England)|September 13, 2012
Tuning the breathing behaviour of MIL-53 by cation mixingFarid Nouar, Thomas Devic, Hubert Chevreau, et al.
Dalton Transactions (Cambridge, England : 2003)|December 6, 2021
Investigation of the preparation and reactivity of metal-organic frameworks of cerium and pyridine-2,4,6-tricarboxylateJuliana Fonseca de Lima, Fernanda V S Moreno, Bruno A T Menezes, et al.
Molecular Cancer Therapeutics|January 8, 2010
The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106Michael I Walton, Paul D Eve, Angela Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202Florence I Raynaud, Steven R Whittaker, Peter M Fischer, et al.
Journal of Medicinal Chemistry|July 4, 2009
Identification of inhibitors of checkpoint kinase 1 through template screeningThomas P Matthews, Suki Klair, Samantha Burns, et al.
Inorganic Chemistry|December 23, 2017
23-Electron Octahedral Molybdenum Cluster Complex [{Mo<sub>6</sub>I<sub>8</sub>}Cl<sub>6</sub>]<sup></sup>Natalya A Vorotnikova, Yuri A Vorotnikov, Igor N Novozhilov, et al.
Genome Biology|September 17, 2016
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancerNnennaya Kanu, Maria Antonietta Cerone, Gerald Goh, et al.
Molecular Cancer Therapeutics|April 29, 2010
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growthKyla M Grimshaw, Lisa-Jane K Hunter, Timothy A Yap, et al.
Journal of Medicinal Chemistry|October 23, 2012
Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitorsMichael Lainchbury, Thomas P Matthews, Tatiana McHardy, et al.
Pageof 20